Prolonged alpha interferon therapy for chronic delta hepatitis: effect on liver histopathology.
David E. Kleiner(National Institutes of Health), Hoofnagle Jh(University of Virginia), Axiotis Ca, Di Bisceglie
PubMed
January 1, 1993
Cited by 7
Related Papers
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
|New England Journal of Medicine|2021|1.1k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889